Bortezomib in Treating Patients With Advanced Cancer and Liver Dysfunction

Clinical trial NCT00091117 · COMPLETED

Trial details

NCT number: NCT00091117
Sponsor: National Cancer Institute (NCI)
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Hepatic Complications Malignant Neoplasm

Start date: 2004-07-01
Primary completion: 2013-03-01
Enrollment: 80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.